NDC product
Trimethobenzamide Hydrochloride
NDC 54288-158 · BPI Labs, LLC
Key facts
| Product NDC | 54288-158 |
|---|---|
| Proprietary name | Trimethobenzamide Hydrochloride |
| Nonproprietary name | Trimethobenzamide Hydrochloride |
| Substances | TRIMETHOBENZAMIDE HYDROCHLORIDE |
| Dosage form | INJECTION |
| Route | INTRAMUSCULAR |
| Labeler | BPI Labs, LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA219606 |
| Pharmacologic classes | Antiemetic [EPC], Emesis Suppression [PE] |
| Marketing start | Jul 1, 2026 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: